EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Single-Cell RNA Sequencing Reveals Immunomodulatory Effects of Stem Cell Factor and Granulocyte Colony-Stimulating Factor Treatment in the Brains of Aged APP/PS1 Mice

Robert S Gardner, Michele Kyle, Karen Hughes, Li-Ru Zhao

Biomolecules · 10.07.2024 · 14 (7) · 827

DOI: 10.3390/biom14070827 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomolecules, online erschienen am 10.07.2024. Verfasst von Robert S Gardner und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, State University of New York Upstate Medical University, 750 E. Adams Street, Syracuse, NY 13210, USA. Hauptthemen laut MEDLINE: Alzheimer Disease, Brain, Granulocyte Colony-Stimulating Factor, Stem Cell Factor. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 151 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIA NIH HHS, The National Institute on Aging of the National Institutes of Health in the United States, National Institute on Aging of the National Institutes of Health in the United States.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alzheimer’s disease (AD) leads to progressive neurodegeneration and dementia. AD primarily affects older adults with neuropathological changes including amyloid-beta (Aβ) deposition, neuroinflammation, and neurodegeneration. We have previously demonstrated that systemic treatment with combined stem cell factor (SCF) and granulocyte colony-stimulating factor (G-CSF) (SCF+G-CSF) reduces the Aβ load, increases Aβ uptake by activated microglia and macrophages, reduces neuroinflammation, and restores dendrites and synapses in the brains of aged APPswe/PS1dE9 (APP/PS1) mice. However, the mechanisms underlying SCF+G-CSF-enhanced brain repair in aged APP/PS1 mice remain unclear. This study used a transcriptomic approach to identify the potential mechanisms by which SCF+G-CSF treatment modulates microglia and peripheral myeloid cells to mitigate AD pathology in the aged brain. After injections of SCF+G-CSF for 5 consecutive days, single-cell RNA sequencing was performed on CD11b+ cells isolated from the brains of 28-month-old APP/PS1 mice. The vast majority of cell clusters aligned with transcriptional profiles of microglia in various activation states. However, SCF+G-CSF treatment dramatically increased a cell population showing upregulation of marker genes related to peripheral myeloid cells. Flow cytometry data also revealed an SCF+G-CSF-induced increase of cerebral CD45high/CD11b+ active phagocytes. SCF+G-CSF treatment robustly increased the transcription of genes implicated in immune cell activation, including gene sets that regulate inflammatory processes and cell migration. The expression of S100a8 and S100a9 was robustly enhanced following SCF+G-CSF treatment in all CD11b+ cell clusters. Moreover, the topmost genes differentially expressed with SCF+G-CSF treatment were largely upregulated in S100a8/9-positive cells, suggesting a well-conserved transcriptional profile related to SCF+G-CSF treatment in resident and peripherally derived CD11b+ immune cells. This S100a8/9-associated transcriptional profile contained notable genes related to pro-inflammatory and anti-inflammatory responses, neuroprotection, and Aβ plaque inhibition or clearance. Altogether, this study reveals the immunomodulatory effects of SCF+G-CSF treatment in the aged brain with AD pathology, which will guide future studies to further uncover the therapeutic mechanisms.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseBrainGranulocyte Colony-Stimulating FactorStem Cell FactorAnimalsMaleMiceAgingAmyloid beta-Protein PrecursorDisease Models, AnimalMice, TransgenicMicrogliaPresenilin-1Sequence Analysis, RNASingle-Cell Analysis

Stichwörter der Autor:innen

Alzheimer’s diseaseS100a8S100a9hematopoietic growth factorsmacrophagesmicrogliamyeloid cellssingle-cell RNA sequencing

Substanzen

Amyloid beta-Protein PrecursorGranulocyte Colony-Stimulating FactorPresenilin-1Stem Cell Factor

Autor:innen und Institutionen

  • Department of Neurosurgery, State University of New York Upstate Medical University, 750 E. Adams Street, Syracuse, NY 13210, USA.

Förderung

  • NIA NIH HHS
  • The National Institute on Aging of the National Institutes of Health in the United States
  • National Institute on Aging of the National Institutes of Health in the United States

Zitieren

APA

Gardner, R. S., Kyle, M., Hughes, K., & Zhao, L. R. (2024). Single-Cell RNA Sequencing Reveals Immunomodulatory Effects of Stem Cell Factor and Granulocyte Colony-Stimulating Factor Treatment in the Brains of Aged APP/PS1 Mice. Biomolecules, 14(7), 827. https://doi.org/10.3390/biom14070827

Vancouver

Gardner RS, Kyle M, Hughes K, Zhao LR. Single-Cell RNA Sequencing Reveals Immunomodulatory Effects of Stem Cell Factor and Granulocyte Colony-Stimulating Factor Treatment in the Brains of Aged APP/PS1 Mice. Biomolecules. 2024;14(7):827. doi:10.3390/biom14070827

BibTeX
@article{Gardner2024,
  author = {Gardner, Robert S and Kyle, Michele and Hughes, Karen and Zhao, Li-Ru},
  title = {Single-Cell RNA Sequencing Reveals Immunomodulatory Effects of Stem Cell Factor and Granulocyte Colony-Stimulating Factor Treatment in the Brains of Aged APP/PS1 Mice},
  journal = {Biomolecules},
  year = {2024},
  volume = {14},
  number = {7},
  pages = {827},
  doi = {10.3390/biom14070827}
}
Kostenlos starten →